Identification and Evaluation of Patients at Risk of Developing Cardiotoxicity After Receiving Chemotherapy for Breast Cancer, Lymphoma or Leukemia
Status: RECRUITING
Study type: OBSERVATIONAL
Conditions: Breast Cancer|Lymphoma|Leukemia
Interventions: DIAGNOSTIC_TEST: Cardiac Imaging|OTHER: Data Collection
Sponsor: Montreal Heart Institute
Collaborators: AstraZeneca